Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSosandar Regulatory News (SOS)

Share Price Information for Sosandar (SOS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.00
Bid: 11.50
Ask: 12.50
Change: 0.00 (0.00%)
Spread: 1.00 (8.696%)
Open: 12.00
High: 12.75
Low: 12.00
Prev. Close: 12.00
SOS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

22 Sep 2017 07:00

RNS Number : 4840R
Orogen PLC
22 September 2017
 



Orogen plc

("Orogen" or the "Company")

Half Yearly Results

 

 

 

Financials

 

In the six months to 30 June 2017 the Company reported turnover of £NIL (2016: £NIL), and a

loss before tax of £733K (2016: loss of £171K).

 

Strategy

 

On 21 March 2017, Orogen announced details of a proposed new strategy and consequent restructuring of its operations. The Board has completed a review of its operations and has concluded that it is no longer in shareholders' interests for the Company to continue to provide financial support for its mineral exploration activities. It is therefore seeking to dispose of its interests in its mineral exploration projects, and to conclude an acquisition which would constitute a reverse takeover under the AIM Rules. The Company has decided to cap further expenditure on its existing mineral exploration projects at £75,000 and to put them on care and maintenance programmes whilst buyers are sought for the Company's interests in these assets.

 

As an initial step in the above restructuring, the Company proposed to undertake a share consolidation and sub-division in order to increase the price at which the Company's shares trade on AIM and to enable the Company to raise funds through the issue of new shares. As part of the proposals that were put to a shareholder vote on 7 April 2017, up to £3.47m of new funds were to be introduced to the Company to implement the new strategy and the Company's name was to be changed to Orogen plc.

 

All resolutions put to shareholders were approved at a general meeting on 7 April 2017. Accordingly, the capital reorganisation and change of the Company name to Orogen plc were completed. 

 

The decision to cease the Company's mineral exploration activities represents a fundamental change of business under Rule 15 of the AIM Rules, a consequence of which is that the Company was deemed to be a Rule 15 Cash Shell which means that the Company must make an acquisition or acquisitions which constitute a reverse takeover under Rule 14 of the AIM Rules within six months of the general meeting, otherwise the trading of the Company's shares on AIM will be suspended.

 

If the Company has not made an acquisition or acquisitions which constitute a reverse takeover under Rule 14 of the AIM Rules within six months of such suspension, the admission of the Company's shares to trading on AIM will be cancelled.

 

On 26 May 2017 the Company's shares were suspended following an announcement advising that Orogen had entered into heads of agreement to acquire the entire issued share capital of Thread 35 Limited ("Thread"), a company that operates an e-commerce womenswear brand under the name "Sosandar". Furthermore, on that date the Company announced that it had made a secured loan of £250,000 to Thread.

 

The Company has subsequently notified that it has loaned a further £500,000 to Thread.

 

The Company is pleased to announce that it continues to undertake due diligence on Thread and is hopeful that it will shortly undertake a reverse transaction with Thread. A further announcement will be made in due course.

 

 

 

ADAM REYNOLDS

Non-Executive Chairman

22 September 2017

 

 

 

 

Consolidated statement of profit or loss and other comprehensive income

For the six months ended 30 June 2017

 

 

 

 

Unaudited

 6 months to

30 June 2017

Unaudited

 6 months to

30 June 2016

Audited

 12 months to

31 December 2016

Notes

£'000

£'000

£'000

General and administrative

(637)

(154)

(334)

Impairment of exploration and evaluation assets

4

(22)

(9)

(2,683)

Share based payments

-

(10)

(20)

From discontinued operations

(74)

-

(49)

Group operating loss

(733)

(173)

(3,086)

Interest received

-

2

3

Loss on ordinary activities before taxation

(733)

(171)

(3,083)

Tax on loss on ordinary activities

-

-

-

Loss for the year from continuing operations

(733)

(171)

(3,083)

 

Attributable to:

Equity holders of the parent

(733)

(171)

(2,609)

Non-controlling interests

0

-

(474)

Group loss for the period

(733)

(171)

(3,083)

Exchange translation differences

(1)

-

66

Total comprehensive loss for the period

(734)

(171)

(3,017)

 

Attributable to:

Owners of the parent

(732)

(171)

(2,543)

Non-controlling interests

(2)

-

(474)

 

(734)

(171)

(3,017)

 

Loss per share:

Loss per share - basic and diluted, attributable to ordinary equity holders of the parent (pence)

3

(0.544)

(0.776)

(10.3)

 

 

 

Consolidated statement of financial position

As at 30 June 2017

 

 

Unaudited

30 June 2017

Unaudited

30 June 2016

Audited

31 December 2016

Notes

£'000

£'000

£'000

Assets

Non-current assets

Exploration and evaluation assets

4

-

1,670

-

Property, plant and equipment

-

2

-

Total non-current assets

-

1,672

-

Current assets

Trade and other receivables

423

27

46

Cash and cash equivalents

5

2,703

652

342

Total current assets

3,126

679

388

Total assets

3,126

2,351

388

Equity and liabilities

Equity

Share capital

6

4,884

4,418

4,651

Share premium

15,535

12,181

12,268

Other reserves

678

635

676

Retained earnings

(18,103)

(14,936)

(17,367)

Equity attributable to owners of the parent

2,994

2,298

228

Non-controlling interests

3

-

3

Total equity

2,997

2,298

231

Current liabilities

Trade and other payables

129

53

157

Total current liabilities

129

53

157

Total liabilities

129

53

157

Total equity and liabilities

3,126

2,351

388

 

 

 

Unaudited

 6 months to

30 June 2016

Unaudited

 6 months to

30 June 2015

Audited

12 months to 31 December 2016

Notes

£'000

£'000

£'000

Cash flows from operating activities

Group operating loss

(733)

(173)

(3,086)

Share based payments

-

10

20

(Increase)/decrease in trade and other receivables

(323)

(5)

91

Decrease in trade and other payables

(83)

(10)

(32)

Impairment of exploration and evaluation assets

4

96

9

2,691

Profit on disposal of subsidiary

-

-

(25)

Net cash flow from operating activities

(1,043)

(169)

(341)

Cash flow from investing activities

Expenditure on exploration and evaluation assets and project earn-ins

4

(96)

(102)

(568)

Outflow on disposal of subsidiary

-

-

(4)

Inflow on acquisition of subsidiary

-

-

11

Interest received

-

2

3

Net cash flow from investing activities

(96)

(100)

(558)

 

Cash flow from financing activities

Net proceeds from issue of equity instruments

6

3,500

-

320

Net cash flow from financing activities

3,500

-

320

 

Net change in cash and cash equivalents

2,361

(269)

(579)

Net foreign exchange difference

-

-

-

Cash and cash equivalents at beginning of period

5

342

921

921

Cash and cash equivalents at end of period

5

2,703

652

342

 

 

 

 

 

 

 

Share capital

 

 

 

Share premium

 

Share based payment reserve

 

 

Retained earnings

Foreign currency translation reserve

 

 

 

Total

 

 

Non-controlling

interests

 

 

 

Total equity

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 1 January 2016

4,418

12,181

597

(14,765)

28

2,459

-

2,459

Loss for the period

-

-

-

(171)

-

(171)

-

(171)

Share based payments

-

-

10

-

-

10

-

10

Balance at 30 June 2016

4,418

12,181

607

(14,936)

28

2,298

-

2,298

Balance at 1 July 2016

4,418

12,181

607

(14,936)

28

2,298

-

2,298

Loss for the period

-

-

-

(2,431)

-

(2,431)

3

(2,428)

Issue of share capital

233

87

-

-

-

320

-

320

Foreign exchange translation reserve

-

-

-

-

38

38

-

38

Share based payments

-

-

3

-

-

3

-

3

Balance at 31 December 2016

4,651

12,268

610

(17,367)

66

228

3

231

Balance at 1 January 2017

4,651

12,268

610

(17,367)

66

228

3

231

Loss for the period

-

-

-

(733)

-

(733)

-

(733)

Issue of share capital

233

3,267

-

-

-

3,500

-

3,500

Foreign exchange translation reserve

-

(1)

(1)

-

(1)

Balance at 30 June 2017

4,884

15,535

610

(18,100)

65

2,994

3

2,997

1 General information

 

Orogen Gold plc is a company incorporated and domiciled in England and Wales. Details of the registered office, the officers and advisers to the Company are presented on the Company information page at the end of this report. The Company's offices are in London and Dublin. The Company is quoted on the AIM market of the London Stock Exchange (ticker: ORE.L).

 

The Mutsk gold exploration project in Armenia is the Company's main operational project and the Silverton project in Nevada, USA was added to the exploration portfolio in April 2016. The company is now classified as an AIM rule 15 cash shell.

 

2 Basis of preparation

The financial information for the six months ended 30 June 2017 and 30 June 2016 is unaudited.

 

The Interim Report has been prepared using the same accounting policies as were applied in the Group's audited financial statements to 31 December 2016, which were prepared in accordance with International Financial Reporting Standards ("IFRS"). As is permitted by the AIM rules the Directors have not adopted the requirements of IAS34 "Interim Financial Reporting" in preparing the financial statements. Accordingly, the financial statements are not in full compliance with IFRS and have neither been audited nor reviewed pursuant to guidance issued by the Auditing Practices Board. The Directors consider that the financial information presented in this Interim Report represents fairly the financial position, operations and cash flows for the period, in conformity with IFRS. The Interim Report for the six months ended 30 June 2017 was approved by the Directors on 21 September 2017.

 

The financial information presented for the period ended 31 December 2016 is an extraction from the Group's audited accounts on which the auditors issued an unqualified report. The information presented does not constitute full accounts for that period.

 

3 Loss per share

Basic loss per share is calculated by dividing the loss attributable to equity shareholders by the weighted average number of ordinary shares in issue during the period:

Unaudited

30 June 2017

Unaudited

30 June 2016

Audited

31 December 2016

£'000

£'000

£'000

Loss after tax attributable to equity holders of the parent

(732)

(171)

(2,609)

Weighted average number of ordinary shares in issue (millions)

134,626

22,030

25,702

Basic and diluted loss per share (pence)

(0.544)

(0.776)

(10.3)

 

Basic and diluted earnings per share are the same, since where a loss is incurred the effect of outstanding share options and warrants is considered anti-dilutive and is ignored for the purpose of the loss per share calculation. The share options outstanding as at 30 June 2017 totalled 380,000,000 (30 June 2016: 380,000,000, 31 December 2016: 380,000,000) and are potentially dilutive.

 

4 Exploration and evaluation assets

 

Armenia

 

Silverton

 

Serbia

 

Total

£'000

£'000

£'000

£'000

Cost

 

 

 

 

At 1 January 2016

1,577

-

5,554

7,131

Additions

87

6

9

102

At 30 June 2016

1,664

6

5,563

7,233

Impairment

 

 

 

 

At 1 January 2016

-

-

5,554

5,554

Impairment charge

-

-

9

9

At 30 June 2016

-

-

5,563

5,563

Carrying value 30 June 2016

1,664

6

-

1,670

Cost

 

 

 

 

At 1 July 2016

1,664

6

5,563

7,233

Additions

851

162

-

1,013

Discontinued operations

-

-

(5,563)

(5,563)

At 31 December 2016

2,515

168

-

2,683

Impairment

 

 

 

 

At 1 July 2016

-

-

5,563

5,563

Impairment charge

2,515

168

-

2,683

Discontinued operations

-

-

(5,563)

(5,563)

At 31 December 2016

2,515

168

-

2,683

Carrying value 31 December 2016

-

-

-

-

Cost

 

 

 

 

At 1 January 2017

2,515

168

-

2,683

Additions

-

-

96

96

At 30 June 2017

2,515

168

96

2,779

Impairment

 

 

 

 

At 1 January 2017

2,515

168

-

2,683

Impairment charge

-

-

96

96

At 30 June 2017

2,515

168

96

2,779

Carrying value 30 June 2017

-

-

-

-

5 Cash and cash equivalents

Unaudited

30 June 2016

Unaudited

30 June 2016

Audited

31 December 2016

£'000

£'000

£'000

Cash at bank

2,703

652

342

Cash and cash equivalents

2,703

652

342

 

 

6 Share capital

Details of ordinary and deferred shares issued are in the table below:

 

Ordinary Shares

 (£0.01)

Deferred Shares

(£0.9)

Deferred Shares

(£0.01)

 

Date

Details

Number of shares

Issue Price £

Number of shares

Issue Price £

Number of shares

Issue Price £

At 1 Jan 2017

Opening Balance

7,841,002,670

429,643,035

7 Apr 2017

Share placing

80

0.0001

7 Apr 2017

Consolidation

(7,809,638,739)

7 Apr 2017

Subdivision

7,809,638,739

0.0001

10 Apr 2017

Share placing

231,364,011

0.015

03 May 2017

Share placing

2,000,000

0.015

At 30 June 2017

Closing Balance

264,728,022

429,643,035

7,809,638,739

 

7 Subsequent events

On 6 July 2017, Orogen announced a further drawdown of Loan to Thread 35 Limited of £250,000. This bring the total outstanding loan amount to £500,000.

 

8 Copy of the Interim Report

Copies of the Interim Report are available to download from the Company's website at www.orogen.co.uk.

 

 

Contacts:-

 

Orogen plc

Adam Reynolds, Non-executive Chairman

 

C/o Walbrook

Cairn Financial Advisers LLP (Nominated Adviser)

Liam Murray / Sandy Jamieson

 

+44 (0) 20 7213 0880

Turner Pope Investments (TPI) Ltd (Broker)

Ben Turner / James Pope

 

+44 (0) 20 3621 4120

Walbrook (Public Relations and Investor Relations)

Paul Cornelius / Gary Middleton

 

+44 (0) 20 7933 8780

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR BSGDCCUDBGRB
Date   Source Headline
16th Apr 20247:00 amRNSFull Year Trading Update
10th Jan 20247:00 amRNSTrading Update
15th Dec 20237:00 amRNSBoard Changes
12th Dec 20237:00 amRNSHalf Year Results
29th Nov 20237:00 amRNSNotice of Results and Investor Presentations
9th Nov 20237:00 amRNSMello Investor Presentation
18th Oct 20237:00 amRNSTrading & Strategic Update
13th Oct 20237:00 amRNSNotice of Trading Update
5th Oct 20232:25 pmRNSHolding(s) in Company
21st Sep 20231:02 pmRNSResult of AGM
25th Aug 20239:45 amRNSNotice of AGM and Posting of Annual Report
11th Jul 20237:00 amRNSFinal Results
4th Jul 20237:00 amRNSNotice of Results and Investor Presentation
17th Apr 20233:13 pmRNSHolding(s) in Company
13th Apr 20232:28 pmRNSHolding(s) in Company
12th Apr 20237:00 amRNSTrading Update & Progress on Growth Strategy
16th Mar 20237:00 amRNSAppointment of Interim Non-Executive Chairman
3rd Mar 20238:12 amRNSDirector/PDMR Dealing
17th Feb 20233:54 pmRNSResult of Retail Offer
17th Feb 20237:00 amRNSClose of Retail Offer
14th Feb 20232:51 pmRNSHolding(s) in Company
13th Feb 202311:55 amRNSHolding(s) in Company
8th Feb 20234:40 pmRNSSecond Price Monitoring Extn
8th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20231:30 pmRNSResult of Placing
8th Feb 20239:16 amRNSRetail Offer
8th Feb 20237:00 amRNSProposed Placing to raise a minimum of £4 million
6th Feb 20237:00 amRNSDeath of Director
23rd Jan 20237:00 amRNSNew Third Party Arrangement
10th Jan 20237:00 amRNSTrading Update
13th Dec 20227:00 amRNSHalf Year Results
17th Nov 20227:00 amRNSNotice of Results and Investor Presentation
15th Nov 20225:25 pmRNSAIM Rule 17 Schedule 2(g) Update
18th Oct 20227:00 amRNSHalf Year Trading Update
15th Sep 20223:24 pmRNSResult of AGM & Notice of Trading Update
22nd Aug 20227:00 amRNSNotice of AGM and Posting of Annual Report
18th Aug 20227:00 amRNSBoard Changes and Change of Auditor
12th Jul 20227:00 amRNSFinal Results
24th Jun 20227:00 amRNSNotice of Results and Investor Presentation
10th Jun 20223:31 pmRNSDirector/PDMR Shareholding
6th May 202212:55 pmRNSDirector/PDMR Dealing
14th Apr 20227:00 amRNSBoard Appointment
6th Apr 20222:05 pmRNSSecond Price Monitoring Extn
6th Apr 20222:00 pmRNSPrice Monitoring Extension
6th Apr 20227:00 amRNSTrading Update and New Third Party Arrangements
6th Jan 20227:00 amRNSTrading Update
20th Dec 20219:00 amRNSExercise of Warrants and Total Voting Rights
30th Nov 20217:00 amRNSHalf Year Results
12th Nov 20217:00 amRNSNotice of Results
7th Oct 202111:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.